605 related articles for article (PubMed ID: 17384583)
1. Protein kinase C and other diacylglycerol effectors in cancer.
Griner EM; Kazanietz MG
Nat Rev Cancer; 2007 Apr; 7(4):281-94. PubMed ID: 17384583
[TBL] [Abstract][Full Text] [Related]
2. PKC isozymes and diacylglycerol-regulated proteins as effectors of growth factor receptors.
Oliva JL; Griner EM; Kazanietz MG
Growth Factors; 2005 Dec; 23(4):245-52. PubMed ID: 16338787
[TBL] [Abstract][Full Text] [Related]
3. New insights into the regulation of protein kinase C and novel phorbol ester receptors.
Ron D; Kazanietz MG
FASEB J; 1999 Oct; 13(13):1658-76. PubMed ID: 10506570
[TBL] [Abstract][Full Text] [Related]
4. Divergence and complexities in DAG signaling: looking beyond PKC.
Yang C; Kazanietz MG
Trends Pharmacol Sci; 2003 Nov; 24(11):602-8. PubMed ID: 14607084
[TBL] [Abstract][Full Text] [Related]
5. Chimaerins: GAPs that bridge diacylglycerol signalling and the small G-protein Rac.
Yang C; Kazanietz MG
Biochem J; 2007 Apr; 403(1):1-12. PubMed ID: 17346241
[TBL] [Abstract][Full Text] [Related]
6. PKC defends crown against Munc13.
Palfreyman M; Jorgensen EM
Neuron; 2007 Apr; 54(2):179-80. PubMed ID: 17442237
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C (PKC) family in cancer progression.
Koivunen J; Aaltonen V; Peltonen J
Cancer Lett; 2006 Apr; 235(1):1-10. PubMed ID: 15907369
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of the receptors for the phorbol ester tumor promoters: multiple receptors with different biochemical properties.
Kazanietz MG; Caloca MJ; Eroles P; Fujii T; García-Bermejo ML; Reilly M; Wang H
Biochem Pharmacol; 2000 Nov; 60(10):1417-24. PubMed ID: 11020443
[TBL] [Abstract][Full Text] [Related]
9. Entamoeba invadens: sphingolipids metabolic regulation is the main component of a PKC signaling pathway in controlling cell growth and proliferation.
Cerbon J; Olguin T; Alvarez-Grave PR; López-Sánchez RC
Exp Parasitol; 2009 Jun; 122(2):106-11. PubMed ID: 19249300
[TBL] [Abstract][Full Text] [Related]
10. Targeting protein kinase C and "non-kinase" phorbol ester receptors: emerging concepts and therapeutic implications.
Kazanietz MG
Biochim Biophys Acta; 2005 Dec; 1754(1-2):296-304. PubMed ID: 16202672
[TBL] [Abstract][Full Text] [Related]
11. Move over protein kinase C, you've got company: alternative cellular effectors of diacylglycerol and phorbol esters.
Brose N; Rosenmund C
J Cell Sci; 2002 Dec; 115(Pt 23):4399-411. PubMed ID: 12414987
[TBL] [Abstract][Full Text] [Related]
12. Interdependence of PKC-dependent and PKC-independent pathways for presynaptic plasticity.
Wierda KD; Toonen RF; de Wit H; Brussaard AB; Verhage M
Neuron; 2007 Apr; 54(2):275-90. PubMed ID: 17442248
[TBL] [Abstract][Full Text] [Related]
13. Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters.
Kazanietz MG
Mol Carcinog; 2000 May; 28(1):5-11. PubMed ID: 10820483
[TBL] [Abstract][Full Text] [Related]
14. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
Chen J; Deng F; Li J; Wang QJ
Biochem J; 2008 Apr; 411(2):333-42. PubMed ID: 18076381
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of PKC isozymes by RNA interference and inducible expression of PKC constructs.
Basu A; Persaud SD; Sivaprasad U
Methods Enzymol; 2008; 446():141-57. PubMed ID: 18603120
[TBL] [Abstract][Full Text] [Related]
16. Differential Regulation of Gene Expression in Lung Cancer Cells by Diacyglycerol-Lactones and a Phorbol Ester Via Selective Activation of Protein Kinase C Isozymes.
Cooke M; Casado-Medrano V; Ann J; Lee J; Blumberg PM; Abba MC; Kazanietz MG
Sci Rep; 2019 Apr; 9(1):6041. PubMed ID: 30988374
[TBL] [Abstract][Full Text] [Related]
17. Exploitation of protein kinase C: a useful target for cancer therapy.
Ali AS; Ali S; El-Rayes BF; Philip PA; Sarkar FH
Cancer Treat Rev; 2009 Feb; 35(1):1-8. PubMed ID: 18778896
[TBL] [Abstract][Full Text] [Related]
18. Diacylglycerol generated during sphingomyelin synthesis is involved in protein kinase C activation and cell proliferation in Madin-Darby canine kidney cells.
Cerbón J; del Carmen López-Sánchez R
Biochem J; 2003 Aug; 373(Pt 3):917-24. PubMed ID: 12691604
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C in cancer: The top five unanswered questions.
Cooke M; Magimaidas A; Casado-Medrano V; Kazanietz MG
Mol Carcinog; 2017 Jun; 56(6):1531-1542. PubMed ID: 28112438
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester-induced apoptosis and senescence in cancer cell models.
Xiao L; Caino MC; von Burstin VA; Oliva JL; Kazanietz MG
Methods Enzymol; 2008; 446():123-39. PubMed ID: 18603119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
